Tian Rong Wang1, Jiang Chen Peng1, Yu Qi Qiao1, Ming Ming Zhu1, Di Zhao1, Jun Shen1, Zhi Hua Ran1. 1. State Key Laboratory for Oncogenes and Related Genes, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, Division of Gastroenterology and Hepatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Cancer Institute, Shanghai Institute of Digestive Disease 145 Middle Shandong Road, Shanghai 200001, China.
Abstract
OBJECTIVE: To investigated the influence of H. pylori on TLR4 and TLR9 in gastric mucosa during gastric carcinogenesis. METHODS: Gastric biopsy specimens were taken from 148 patients and divided into five groups, including normal group (n = 10), chronic superficial gastritis group (n = 35), atrophy/intestinal metaplasia group (n = 35), dysplasia group (n = 34) and gastric carcinoma group (n = 34). Immunohistochemistry was used to detect the expression of TLR4 and TLR9. Geimsa staining and rapid urea test were used for determine H. pylori infection. RESULTS: TLR4 was detected in gastric epithelium and monocytes/macrophages in superficial gastritis, atrophy/intestinal metaplasia, dysplasia or carcinoma. TLR9 was mainly accentuated in monocytes/macrophages. TLR4 positive cells in epithelium and in monocytes/macrophages with H. pylori infection were much more than those without H. pylori infection. Similar results were also found in TLR9. When gastric epithelium was accompanied with H. pylori infection, TLR4 was significant higher in superficial gastritis and atrophy/intestinal metaplasia groups compared with dysplasia and carcinoma groups. When gastric epithelium was infected by H. pylori, TLR9 was significant higher in carcinoma group compared with superficial gastritis, atrophy/intestinal metaplasia and dysplasia. TLR4 and TLR9 show significant correlation with the severity of inflammation. CONCLUSIONS: H. pylori infection was associated with increased expression of TLR4 and TLR9 in gastric mucosa. In superficial gastritis and atrophy/intestinal metaplasia the inflammation was predominately mediated by TLR4, while in gastric cancer the inflammation was mainly mediated by TLR9.
OBJECTIVE: To investigated the influence of H. pylori on TLR4 and TLR9 in gastric mucosa during gastric carcinogenesis. METHODS: Gastric biopsy specimens were taken from 148 patients and divided into five groups, including normal group (n = 10), chronic superficial gastritis group (n = 35), atrophy/intestinal metaplasia group (n = 35), dysplasia group (n = 34) and gastric carcinoma group (n = 34). Immunohistochemistry was used to detect the expression of TLR4 and TLR9. Geimsa staining and rapid urea test were used for determine H. pyloriinfection. RESULTS: TLR4 was detected in gastric epithelium and monocytes/macrophages in superficial gastritis, atrophy/intestinal metaplasia, dysplasia or carcinoma. TLR9 was mainly accentuated in monocytes/macrophages. TLR4 positive cells in epithelium and in monocytes/macrophages with H. pyloriinfection were much more than those without H. pyloriinfection. Similar results were also found in TLR9. When gastric epithelium was accompanied with H. pyloriinfection, TLR4 was significant higher in superficial gastritis and atrophy/intestinal metaplasia groups compared with dysplasia and carcinoma groups. When gastric epithelium was infected by H. pylori, TLR9 was significant higher in carcinoma group compared with superficial gastritis, atrophy/intestinal metaplasia and dysplasia. TLR4 and TLR9 show significant correlation with the severity of inflammation. CONCLUSIONS:H. pyloriinfection was associated with increased expression of TLR4 and TLR9 in gastric mucosa. In superficial gastritis and atrophy/intestinal metaplasia the inflammation was predominately mediated by TLR4, while in gastric cancer the inflammation was mainly mediated by TLR9.
Entities:
Keywords:
Expression of Toll-like receptor; H. pylori; gastric carcinogenesis
Authors: P D Smith; L E Smythies; M Mosteller-Barnum; D A Sibley; M W Russell; M Merger; M T Sellers; J M Orenstein; T Shimada; M F Graham; H Kubagawa Journal: J Immunol Date: 2001-09-01 Impact factor: 5.422
Authors: Marina Oldenburg; Anne Krüger; Ruth Ferstl; Andreas Kaufmann; Gernot Nees; Anna Sigmund; Barbara Bathke; Henning Lauterbach; Mark Suter; Stefan Dreher; Uwe Koedel; Shizuo Akira; Taro Kawai; Jan Buer; Hermann Wagner; Stefan Bauer; Hubertus Hochrein; Carsten J Kirschning Journal: Science Date: 2012-07-19 Impact factor: 47.728
Authors: Y Kitadai; Y Takahashi; K Haruma; K Naka; K Sumii; H Yokozaki; W Yasui; N Mukaida; Y Ohmoto; G Kajiyama; I J Fidler; E Tahara Journal: Br J Cancer Date: 1999-10 Impact factor: 7.640
Authors: Anna K Miller; Gloria Tavera; Scott M Williams; Douglas R Morgan; Ricardo L Dominguez; M Constanza Camargo; Tim Waterboer; Keith T Wilson Journal: Oncogene Date: 2021-08-10 Impact factor: 9.867
Authors: M G Varga; C L Shaffer; J C Sierra; G Suarez; M B Piazuelo; M E Whitaker; J Romero-Gallo; U S Krishna; A Delgado; M A Gomez; J A D Good; F Almqvist; E P Skaar; P Correa; K T Wilson; M Hadjifrangiskou; R M Peek Journal: Oncogene Date: 2016-05-09 Impact factor: 9.867
Authors: Ana Maria Sampaio; Sandra Caramujo Balseiro; Maria Reis Silva; Ana Alarcão; Maria João d'Aguiar; Teresa Ferreira; Lina Carvalho Journal: GE Port J Gastroenterol Date: 2015-07-04
Authors: Manoela Dias Susi; de Matos Lourenço Caroline; Lucas Trevizani Rasmussen; Spencer Luis Marques Payão; Ana Flávia Teixeira Rossi; Ana Elizabete Silva; Juliana Garcia de Oliveira-Cucolo Journal: World J Gastrointest Oncol Date: 2019-11-15